Literature DB >> 29205102

CRISPR/Cas9 Editing of the Mouse Thra Gene Produces Models with Variable Resistance to Thyroid Hormone.

Suzy Markossian1, Romain Guyot1, Sabine Richard1, Marie Teixeira2, Nadine Aguilera2, Mathilde Bouchet1, Michelina Plateroti3, Wenyue Guan1, Karine Gauthier1, Denise Aubert1, Frédéric Flamant1.   

Abstract

BACKGROUND: Resistance to thyroid hormone due to THRA mutations (RTHα) is a recently discovered genetic disease, displaying important variability in its clinical presentation. The mutations alter the function of TRα1, one of the two nuclear receptors for thyroid hormone.
METHODS: The aim of this study was to understand the relationship between specific THRA mutations and phenotype. CRISPR/Cas9 genome editing was used to generate five new mouse models of RTHα, with frameshift or missense mutations.
RESULTS: Like human patients, mutant mice displayed a hypothyroid-like phenotype, with altered development. Phenotype severity varied between the different mouse models, mainly depending on the ability of the mutant receptor to interact with transcription corepressor in the presence of thyroid hormone.
CONCLUSION: The present mutant mice represent highly relevant models for the human genetic disease which will be useful for future investigations.

Entities:  

Keywords:  CRISPR/Cas9; mouse model; nuclear receptor

Mesh:

Year:  2018        PMID: 29205102     DOI: 10.1089/thy.2017.0389

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  9 in total

Review 1.  Role of thyroid hormones in craniofacial development.

Authors:  Victoria D Leitch; J H Duncan Bassett; Graham R Williams
Journal:  Nat Rev Endocrinol       Date:  2020-01-23       Impact factor: 43.330

2.  New Case of Thyroid Hormone Resistance α Caused by a Mutation of THRA /TRα1.

Authors:  Hui Sun; Haiying Wu; Rongrong Xie; Fengyun Wang; Ting Chen; Xiuli Chen; Xiaoyan Wang; Frédéric Flamant; Linqi Chen
Journal:  J Endocr Soc       Date:  2019-02-04

3.  Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches.

Authors:  Pamela D Noyes; Katie Paul Friedman; Patience Browne; Jonathan T Haselman; Mary E Gilbert; Michael W Hornung; Stan Barone; Kevin M Crofton; Susan C Laws; Tammy E Stoker; Steven O Simmons; Joseph E Tietge; Sigmund J Degitz
Journal:  Environ Health Perspect       Date:  2019-09-05       Impact factor: 9.031

Review 4.  Gene surgery: Potential applications for human diseases.

Authors:  Ayman El-Kenawy; Bachir Benarba; Adriana Freitas Neves; Thaise Gonçalves de Araujo; Bee Ling Tan; Adel Gouri
Journal:  EXCLI J       Date:  2019-10-11       Impact factor: 4.068

Review 5.  Thyroid Hormone Hyposensitivity: From Genotype to Phenotype and Back.

Authors:  Giuditta Rurale; Emery Di Cicco; Monica Dentice; Domenico Salvatore; Luca Persani; Federica Marelli; Cristina Luongo
Journal:  Front Endocrinol (Lausanne)       Date:  2020-01-24       Impact factor: 5.555

6.  7SK Acts as an Anti-tumor Factor in Tongue Squamous Cell Carcinoma.

Authors:  Bowen Zhang; Sainan Min; Qi Guo; Yan Huang; Yuzhu Guo; Xiaolin Liang; Li-Ling Wu; Guang-Yan Yu; Xiangting Wang
Journal:  Front Genet       Date:  2021-04-01       Impact factor: 4.599

7.  A Pivotal Genetic Program Controlled by Thyroid Hormone during the Maturation of GABAergic Neurons.

Authors:  Sabine Richard; Romain Guyot; Martin Rey-Millet; Margaux Prieux; Suzy Markossian; Denise Aubert; Frédéric Flamant
Journal:  iScience       Date:  2020-02-08

Review 8.  Advances in CRISPR/Cas-based Gene Therapy in Human Genetic Diseases.

Authors:  Shao-Shuai Wu; Qing-Cui Li; Chang-Qing Yin; Wen Xue; Chun-Qing Song
Journal:  Theranostics       Date:  2020-03-15       Impact factor: 11.556

9.  Structure-Guided Approach to Relieving Transcriptional Repression in Resistance to Thyroid Hormone α.

Authors:  Beatriz Romartinez-Alonso; Maura Agostini; Heulyn Jones; Jayde McLellan; D Eilidh Sood; Nicholas Tomkinson; Federica Marelli; Ilaria Gentile; W Edward Visser; Erik Schoenmakers; Louise Fairall; Martin Privalsky; Carla Moran; Luca Persani; Krishna Chatterjee; John W R Schwabe
Journal:  Mol Cell Biol       Date:  2021-12-06       Impact factor: 4.272

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.